Skip to Content

The Medical Letter on Drugs and Therapeutics
Objective, peer-reviewed evaluations of new FDA-approved drugs, and new information on previously approved drugs.
April 13, 2015 (Issue 1466)
  • Carbidopa/Levodopa Extended-Release Capsules (Rytary)
  • Empagliflozin/Linagliptin (Glyxambi) for Diabetes
  • Netupitant/Palonosetron (Akynzeo) for Chemotherapy-Induced Nausea and Vomiting
  • Drugs for Psoriasis and Psoriatic Arthritis
  • Umeclidinium (Incruse Ellipta) for COPD
Treatment Guidelines from The Medical Letter
Unbiased reviews of drug classes used to treat common disorders. Includes the doses, adverse effects and the recommendations of expert reviewers.
June 2014 (Issue 142)
  • Vaccines recommended for adults residing in the US are reviewed here. Vaccines for travel have been reviewed separately.

    Eight vaccines are currently recommended by the US Advisory Committee on Immunization Practices (ACIP) for routine use in adults at various ages... [more]